Medifast, Inc.
MED
$13.63
-$0.46-3.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -43.80% | -44.64% | -43.90% | -41.32% | -32.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.80% | -44.64% | -43.90% | -41.32% | -32.94% |
| Cost of Revenue | -46.71% | -47.72% | -48.15% | -44.36% | -33.58% |
| Gross Profit | -42.69% | -43.45% | -42.23% | -40.12% | -32.69% |
| SG&A Expenses | -32.40% | -32.52% | -33.52% | -36.44% | -32.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.73% | -37.27% | -38.14% | -38.88% | -32.53% |
| Operating Income | -96.69% | -92.53% | -80.80% | -57.97% | -35.84% |
| Income Before Tax | -97.06% | -91.87% | -78.41% | -52.28% | -30.02% |
| Income Tax Expenses | -94.23% | -84.16% | -80.01% | -52.55% | -27.43% |
| Earnings from Continuing Operations | -97.90% | -93.89% | -77.94% | -52.20% | -30.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.90% | -93.89% | -77.94% | -52.20% | -30.75% |
| EBIT | -96.69% | -92.53% | -80.80% | -57.97% | -35.84% |
| EBITDA | -90.11% | -87.48% | -75.35% | -53.84% | -32.92% |
| EPS Basic | -97.89% | -93.88% | -77.89% | -51.59% | -28.54% |
| Normalized Basic EPS | -96.04% | -91.67% | -79.09% | -54.07% | -32.38% |
| EPS Diluted | -98.02% | -94.02% | -77.91% | -51.46% | -28.22% |
| Normalized Diluted EPS | -96.08% | -91.70% | -79.09% | -53.95% | -32.12% |
| Average Basic Shares Outstanding | 0.42% | 0.27% | 0.00% | -1.16% | -2.79% |
| Average Diluted Shares Outstanding | 0.38% | 0.13% | -0.20% | -1.41% | -3.16% |
| Dividend Per Share | -- | -100.00% | -74.92% | -49.77% | -24.54% |
| Payout Ratio | -0.53% | 3.19% | 1.28% | 0.54% | 0.47% |
